home / stock / sigy / sigy quote
Last: | $5.25 |
---|---|
Change Percent: | 0.0% |
Open: | $5.25 |
Close: | $5.25 |
High: | $5.25 |
Low: | $5.25 |
Volume: | 300 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.25 | $5.25 | $5.25 | $5.25 | $5.25 | 300 | 05-03-2024 |
$5.25 | $5.25 | $5.25 | $5.25 | $5.25 | 200 | 05-02-2024 |
$5.5 | $5.75 | $5.5 | $5.75 | $5.5 | 400 | 05-01-2024 |
$6 | $6 | $6 | $6 | $6 | 290 | 04-30-2024 |
$6.34 | $0 | $6.34 | $0 | $0 | 10 | 04-29-2024 |
$6.34 | $6.25 | $6.34 | $6.34 | $6.25 | 200 | 04-26-2024 |
$5.75 | $5.75 | $5.75 | $5.75 | $5.75 | 256 | 04-19-2024 |
$5.5 | $5.8 | $5.5 | $5.8 | $5.5 | 383 | 04-18-2024 |
$6.1 | $0 | $6.1 | $0 | $0 | 25 | 04-17-2024 |
$6.1 | $6.1 | $6.1 | $6.1 | $6.1 | 100 | 04-15-2024 |
$6 | $6.25 | $6 | $6.25 | $6 | 200 | 04-12-2024 |
$5.5 | $0 | $5.5 | $0 | $0 | 5 | 04-03-2024 |
$5.5 | $6 | $5.5 | $6 | $5.5 | 519 | 03-29-2024 |
$5.5 | $6 | $5.5 | $6 | $5.5 | 519 | 03-28-2024 |
$4.5 | $0 | $4.5 | $0 | $0 | 37 | 03-27-2024 |
$4.5 | $4.5 | $4.5 | $4.5 | $4.5 | 513 | 03-26-2024 |
$5 | $5 | $5 | $5 | $5 | 305 | 03-05-2024 |
$5 | $5 | $5 | $5 | $5 | 495 | 03-04-2024 |
$0.15 | $0.139 | $0.15 | $0.199 | $0.12 | 46,891 | 01-30-2024 |
$0.129 | $0.129 | $0.129 | $0.129 | $0.129 | 1,884 | 01-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Sigyn Therapeutics Inc Company Name:
SIGY Stock Symbol:
OTCMKTS Market:
Sigyn Therapeutics (OTCQB: SIGY) , a medical technology that creates medical solutions to treat life-threatening conditions, is developing a portfolio of technologies, including Sigyn Therapy(TM), ChemoPrep(TM), ChemoPure(TM) and ImmunePrep(TM), which have each been designed to overcome a current...
Sigyn Therapeutics (OTCQB: SIGY) , a medical technology company, is developing blood purification technologies to treat life-threatening conditions that are not addressed with current market-cleared drug agents as well as an expansive pipeline of technologies to optimize the benefit of cancer the...
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, recently expanded its therapeutic candidates, introducing ImmunePrep(TM) to improve the delivery of immunotherapeutic antibodies to treat cancer. “The company is also developing ChemoPrep(TM) and ChemoP...